By expenditures
| Name | Title | Type |
|---|---|---|
| Melody Milroy | Cfo | Auditee |
| Stefeni Freese | SHAREHOLDER | Auditee |
| Stefeni Freese | Principal | Auditee |
| Jill Galle | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 375900 | 2025 | 2025-12-18 | KCOE ISOM LLP | $16.44M |
| 332801 | 2024 | 2024-12-16 | Kcoe Isom LLP | $15.86M |
| 6864 | 2023 | 2023-12-15 | Kcoe Isom LLP | $17.37M |
| 27057 | 2022 | 2022-12-11 | Anderson Zurmuehlen & CO | $18.19M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 375900 | 2025 | 2025-12-18 | 1165325 | 2025-003 | Material Weakness | Yes | N |
| 375900 | 2025 | 2025-12-18 | 1165324 | 2025-003 | Material Weakness | Yes | N |
| 375900 | 2025 | 2025-12-18 | 1165323 | 2025-003 | Material Weakness | Yes | N |
| 375900 | 2025 | 2025-12-18 | 1165322 | 2025-003 | Material Weakness | Yes | N |
| 375900 | 2025 | 2025-12-18 | 1165321 | 2025-003 | Material Weakness | Yes | N |
| 375900 | 2025 | 2025-12-18 | 1165320 | 2025-002 | Material Weakness | Yes | E |
| 375900 | 2025 | 2025-12-18 | 1165319 | 2025-002 | Material Weakness | Yes | E |
| 375900 | 2025 | 2025-12-18 | 1165318 | 2025-002 | Material Weakness | Yes | E |
| 375900 | 2025 | 2025-12-18 | 1165317 | 2025-002 | Material Weakness | Yes | E |
| 375900 | 2025 | 2025-12-18 | 1165316 | 2025-002 | Material Weakness | Yes | E |
| 375900 | 2025 | 2025-12-18 | 1165315 | 2025-001 | Material Weakness | Yes | N |
| 375900 | 2025 | 2025-12-18 | 1165314 | 2025-001 | Material Weakness | Yes | N |
| 375900 | 2025 | 2025-12-18 | 1165313 | 2025-001 | Material Weakness | Yes | N |
| 375900 | 2025 | 2025-12-18 | 1165312 | 2025-001 | Material Weakness | Yes | N |
| 375900 | 2025 | 2025-12-18 | 1165311 | 2025-001 | Material Weakness | Yes | N |
| 332801 | 2024 | 2024-12-16 | 1090911 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 1090910 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 1090909 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 1090908 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 1090907 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 1090906 | 2024-001 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 514469 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 514468 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 514467 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 514466 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 514465 | 2024-002 | Significant Deficiency | - | N |
| 332801 | 2024 | 2024-12-16 | 514464 | 2024-001 | Significant Deficiency | - | N |
| 6864 | 2023 | 2023-12-15 | 580854 | 2023-002 | Significant Deficiency | - | L |
| 6864 | 2023 | 2023-12-15 | 580853 | 2023-001 | Significant Deficiency | - | AB |
| 6864 | 2023 | 2023-12-15 | 4412 | 2023-002 | Significant Deficiency | - | L |
| 6864 | 2023 | 2023-12-15 | 4411 | 2023-001 | Significant Deficiency | - | AB |